Lifecore Biomedical
Scott Collins is a Vice President of Finance at Lifecore Biomedical since January 2001. Prior to their current role, Scott held various finance positions within the company, including Senior Director of Finance, Director of Finance, Controller, Asst. Controller, and Senior Accountant. Before joining Lifecore Biomedical, Scott worked as a Senior Accountant at LarsonAllen from September 1996 to May 1999. Scott obtained their education from the University of Northern Iowa, graduating in 1996.
Lifecore Biomedical
Lifecore Biomedical is a full-service contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to develop and deliver vital and complex injectable therapies. From formulation to commercialization, we have everything it takes to move your project to the next level, making progress possible for our partners, people and most importantly, patients. Working from two dedicated, state-of-the-art facilities, our people are subject matter experts, our capabilities customized, our processes and systems qualified and our infrastructure optimized to meet your most sophisticated requirements regardless of scale. Our expertise is in drug products that are challenging and difficult to formulate, sterile filter, and aseptically fill. We've been the global leader in pharmaceutical-grade sodium hyaluronate (NaHy) for nearly 40 years. Leveraging this experience alongside deep expertise and capabilities in highly viscous solutions, we create tailored solutions that solve your drug development challenges across the entire development and manufacturing lifecycle. Our capabilities: Sterile Injectable Development - Formulation Development - Sterilization Development - Process Development - Analytical Services & Stability - Engineering Services - Validation Services Sterile Injectable Manufacturing - Sterilization - Aseptic Filling - Packaging - Analytical Services & Stability